Related Experiment Video

Updated: Jul 23, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy

Ranjana Arya1, Vishram Kedar, Jae Ryoung Hwang

  • 1Carolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, NC 27599, USA.

The Journal of Cell Biology
|December 15, 2004
PubMed

Insights

Muscle Ring Finger Protein-1 (MURF1) inhibits cardiac hypertrophy by blocking protein kinase C (PKC) signaling. This novel anti-hypertrophic pathway reveals MURF1 as a key regulator of cardiomyocyte growth.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Signaling

Background:

  • Cardiac hypertrophy is a significant cardiovascular disease.
  • Mechanisms inhibiting hypertrophic growth remain largely unknown.
  • Understanding inhibitory pathways is crucial for therapeutic development.

Purpose of the Study:

  • To identify and characterize novel anti-hypertrophic signaling pathways.
  • To investigate the role of Muscle Ring Finger Protein-1 (MURF1) in regulating cardiac hypertrophy.
  • To elucidate the molecular mechanisms by which MURF1 inhibits cardiomyocyte growth.

Main Methods:

  • Utilized neonatal rat ventricular myocytes.
  • Investigated protein interactions using co-immunoprecipitation and colocalization studies.
  • Assessed the impact of MURF1 on protein kinase C (PKC) signaling, focal adhesion formation, and ERK1/2 activity.
  • Measured cardiomyocyte cell size changes in response to specific agonists.

Main Results:

  • Identified a novel anti-hypertrophic pathway regulated by MURF1.
  • Demonstrated that MURF1 interacts with Receptor for Activated Protein Kinase C (RACK1).
  • Showed that MURF1 inhibits PKCepsilon translocation to focal adhesions, reduces focal adhesion formation, and suppresses ERK1/2 activity.
  • Confirmed that MURF1 inhibits phenylephrine-induced but not IGF-1-induced cardiomyocyte hypertrophy.

Conclusions:

  • MURF1 acts as a key regulator of the PKC-dependent hypertrophic response.
  • MURF1 effectively blunts cardiomyocyte hypertrophy.
  • These findings have potential implications for the pathophysiology and treatment of clinical cardiac hypertrophy.

More Related Videos

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity08:00

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

Published on: July 10, 2019

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...